Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

’Real life’ study clarifies risk of recurrence for high-risk breast cancer patients

06.06.2005


High-risk breast cancer patients do not appear to have a higher risk of relapse than the general breast cancer population during the first two years after diagnosis, unless their cancer has spread to more than 10 axillary lymph nodes, Italian researchers reported today at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.


Dr. Marina Cazzaniga from Treviglio Hospital, Italy, and colleagues in the NORA study, have been studying 3,500 patients being treated for breast cancer. They identified five groups of patients considered at high risk and analyzed their rate of relapse.

The five groups were:

  • patients whose tumors were estrogen receptor positive/progesterone receptor negative (ER+/PgR-)
  • those who had tumors with a 3+ score for HER2 protein overexpression
  • those with 1 to 3 positive axillary nodes
  • those with 4 to 10 positive nodes
  • patients with more than 10 positive nodes

"We found that patients with ER+/PgR- status, or high expression of HER2 or fewer than 10 positive axillary nodes do not seem to have an increased risk of relapse in comparison to the whole population," Dr. Cazzaniga said. "Massive involvement of axillary nodes seems to be the only factor associated with a higher risk of developing distant or local relapse."

"Our results reflect what happens in an unselected population of breast cancer patients, so they are very close to the clinical reality," Dr. Cazzaniga added. "In clinical practice, benefits do not derive only from one study, but from an accurate use of different strategies resulting from different trials and tailored to individual patients. Our study probably reflects the magnitude of benefits of the application of various studies on the whole population."



The finding could be very important for patients, she said. "The identification of peculiar characteristics allows clinicians to design specific therapies for specific patients. That’s why results must fit clinical practice."

Median follow-up in the study so far is 21.7 months. The risk of recurrence in breast cancer patients presents 2 peaks: the first approximately within 2 years, the second 5 years after surgery.

"We believe our results well describe the natural history of breast cancer in the first 2 years. Longer follow-up will demonstrate if also the second peak changes or not," Dr. Cazzaniga said.

Commenting on the report, Dr. Ahmad Awada from Jules Bordet Institute, Brussels, Belgium, said, "At this time we do not know which patients would benefit most from upfront therapy with aromatase inhibitors compared to the sequential approach of Tamoxifen followed by aromatase inhibitors. This paper showed that patients with N+>10 had an increased risk of relapse during the first 2 years. Consequently, these data called for an upfront use of adjuvant AI in this group of patients at high risk of relapse in the first 2 years."

Gracemarie Bricalli | EurekAlert!
Further information:
http://www.esmo.org

More articles from Studies and Analyses:

nachricht Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>